{"id":13868,"date":"2026-08-10T13:48:27","date_gmt":"2026-08-10T13:48:27","guid":{"rendered":"https:\/\/veilles-affaires-sociales.fr\/?p=13868"},"modified":"2026-08-17T12:04:45","modified_gmt":"2026-08-17T12:04:45","slug":"illegal-promotion-of-cell-therapy-we-are-taking-new-public-health-enforcement-decisionstitre-traduit-en-francais-par-lia","status":"publish","type":"post","link":"https:\/\/veilles-affaires-sociales.fr\/?p=13868","title":{"rendered":"Promotion ill\u00e9gale de th\u00e9rapie cellulaire : nous prenons de nouvelles d\u00e9cisions de police sanitaire"},"content":{"rendered":"<p>Le document signale l\u2019offre, par les sites internet Liv Hospital et You StemCell, de th\u00e9rapies par cellules souches, seules ou associ\u00e9es \u00e0 des exosomes, pr\u00e9sent\u00e9es comme des traitements de diverses pathologies graves (autisme, paralysie c\u00e9r\u00e9brale, scl\u00e9rose en plaques, maladie d\u2019Alzheimer, maladie de Parkinson, diab\u00e8te, infertilit\u00e9, scl\u00e9rose lat\u00e9rale amyotrophique). Ces produits rel\u00e8vent de la d\u00e9finition du m\u00e9dicament mais ne disposent d\u2019aucune autorisation de mise sur le march\u00e9 (AMM) en France ni au niveau de l\u2019Union europ\u00e9enne. En cons\u00e9quence, aucune donn\u00e9e robuste n\u2019atteste de leur efficacit\u00e9, de leur s\u00e9curit\u00e9 ou de leur qualit\u00e9.<\/p>\n<p>Les autorit\u00e9s sanitaires fran\u00e7aises, en particulier l\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM), n\u2019ont d\u00e9livr\u00e9 aucun visa de publicit\u00e9 \u00e0 ces soci\u00e9t\u00e9s, qui ne sont donc pas autoris\u00e9es \u00e0 promouvoir ces th\u00e9rapies. Le texte souligne les risques pour la sant\u00e9 des patients, ainsi que le risque de perte de chance lorsque ces traitements non autoris\u00e9s conduisent des patients \u00e0 renoncer ou \u00e0 retarder la mise en \u0153uvre de traitements valid\u00e9s dont les b\u00e9n\u00e9fices et les risques ont \u00e9t\u00e9 \u00e9valu\u00e9s par les autorit\u00e9s comp\u00e9tentes. L\u2019information met en \u00e9vidence un enjeu de r\u00e9gulation de la publicit\u00e9 et de la mise sur le march\u00e9 de produits de th\u00e9rapie innovante, ainsi que de protection des patients contre des all\u00e9gations th\u00e9rapeutiques non fond\u00e9es.\u00a0(contenu r\u00e9sum\u00e9 en fran\u00e7ais par l&rsquo;IA)<a href=\"https:\/\/ansm.sante.fr\/actualites\/promotion-illegale-de-therapie-cellulaire-nous-prenons-de-nouvelles-decisions-de-police-sanitaire\" target=\"_blank\" class=\"feedzy-rss-link-icon\">Lire la Suite<\/a>\u200b<\/p>","protected":false},"excerpt":{"rendered":"<p>Le document signale l\u2019offre, par les sites internet Liv Hospital et You StemCell, de th\u00e9rapies par cellules souches, seules ou associ\u00e9es \u00e0 des exosomes, pr\u00e9sent\u00e9es comme des traitements de diverses [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3852,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[7],"tags":[63],"class_list":["post-13868","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicaments-et-produits-de-sante","tag-ansm"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/13868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13868"}],"version-history":[{"count":2,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/13868\/revisions"}],"predecessor-version":[{"id":14919,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/13868\/revisions\/14919"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/3852"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13868"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}